Change search
ReferencesLink to record
Permanent link

Direct link
Pertussis-Specific Memory B-Cell and Humoral IgG Responses in Adolescents after a Fifth Consecutive Dose of Acellular Pertussis Vaccine
Public Health Agency Sweden, Sweden; Karolinska Institute, Sweden.
Public Health Agency Sweden, Sweden.
Public Health Agency Sweden, Sweden.
Linköping University, Department of Clinical and Experimental Medicine, Division of Inflammation Medicine. Linköping University, Faculty of Health Sciences.
Show others and affiliations
2014 (English)In: Clinical and Laboratory Immunology, ISSN 1556-6811, E-ISSN 1556-679X, Vol. 21, no 9, 1301-1308 p.Article in journal (Refereed) Published
Abstract [en]

In order to impede the increase in pertussis incidence in the adolescent group, a school-leaving booster dose administered at the age of 14 to 16 years will be introduced in Sweden in 2016. Preceding this introduction, an open-label, randomized, multicenter, clinical trial without a control group and with blinded analysis was performed, investigating both safety and immunogenicity. Reported here are the memory B-cell and serological responses detected in a smaller cohort (n = 34) of the 230 subjects recruited to the study. All subjects had received primary vaccination consisting of three doses of diphtheria-tetanus-5-component pertussis (DTaP5) vaccine, at 3, 5, and 12 months of age, and a tetanus-low-dose diphtheria-5-component pertussis (Tdap5) vaccine booster at 5.5 years. In this study, the subjects were randomly assigned and received either a Tdap1 or Tdap5 booster. Of the 230 participants, 34 subjects had samples available for evaluation of IgG-producing memory B-cell responses. Both vaccine groups had significant increases in pertussis toxin-specific serum IgG levels, but only the 1-component group showed significant increases in pertussis toxin-specific memory B cells. The 5-component group had significant increases in filamentous hemagglutinin- and pertactin-specific memory B-cell and serum IgG levels; these were not seen in the 1-component group, as expected. In conclusion, this study shows that a 5th consecutive dose of an acellular pertussis vaccine induces B-cell responses in vaccinated adolescents.

Place, publisher, year, edition, pages
American Society for Microbiology , 2014. Vol. 21, no 9, 1301-1308 p.
National Category
Clinical Medicine
URN: urn:nbn:se:liu:diva-111261DOI: 10.1128/CVI.00280-14ISI: 000341624800015PubMedID: 25008903OAI: diva2:755594

Funding Agencies|Statens Serum Institute; Sanofi Pasteur MSD (Sweden)

Available from: 2014-10-15 Created: 2014-10-14 Last updated: 2014-10-16

Open Access in DiVA

fulltext(877 kB)121 downloads
File information
File name FULLTEXT01.pdfFile size 877 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Jenmalm, MariaNilsson, Lennart
By organisation
Division of Inflammation MedicineFaculty of Health SciencesAllergy Center
In the same journal
Clinical and Laboratory Immunology
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 121 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 108 hits
ReferencesLink to record
Permanent link

Direct link